Preliminary analysis on the treatment of ventilator-associated pneumonia caused by pandrug-resistant Acinetobacter baumannii

Acta Academiae Medicinae Sinicae

Volumn 36, Issue 2, 2014, Pages 185-188

  Li wan, Wang ^a   Lin, Zou ^a   Hong xia, L I ^a   Tian zhi, L I ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Cefoperazone sulbactam; Influencing factor; Minocycline; Pandrug resistant Acinetobacter baumannii

Indexed keywords

ANTIBIOTIC AGENT; CEFOPERAZONE PLUS SULBACTAM; MINOCYCLINE; ANTIINFECTIVE AGENT; CEFOPERAZONE; SULBACTAM;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; AGED; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL CLEARANCE; BACTERIAL STRAIN; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ERADICATION; DRUG EFFICACY; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MECHANICAL VENTILATOR; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PANDRUG RESISTANT ACINETOBACTER BAUMANNII; RETROSPECTIVE STUDY; VENTILATOR ASSOCIATED PNEUMONIA; DRUG COMBINATION; FEMALE; MALE; MICROBIOLOGY; MULTIDRUG RESISTANCE; PNEUMONIA, VENTILATOR-ASSOCIATED; TREATMENT OUTCOME; VERY ELDERLY;

ACINETOBACTER BAUMANNII; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CEFOPERAZONE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MINOCYCLINE; PNEUMONIA, VENTILATOR-ASSOCIATED; RETROSPECTIVE STUDIES; SULBACTAM; TREATMENT OUTCOME;

EID: 84901319005     PISSN: 1000503X     EISSN: None     Source Type: Journal    
DOI: 10.3881/j.issn.1000-503X.2014.02.013     Document Type: Article

References (14)

1. Garnacho-Montero J, Ortiz-Leyba C, Fernandez-Hinojosa E, et al. Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings [J]. Intensive Care Med, 2005, 31(5):649-655. (Pubitemid 40684982)
2. Bassetti M, Righi E, Esposito S, et al. Nosocomial pneumonia due to Acinetobacter baumannii [J]. Enferm Infecc Microbiol Clin, 2005, 23(Suppl 3):46-51.
3. Wieczorek P, Sacha P, Hauschild T, et al. Multidrug resistant Acinetobacter baumannii-the role of AdeABC (RND family) efflux pump in resistance to antibiotics [J]. Folia Histochem Cytobiol, 2008, 46(3):257-267.
4. Mendes RE, Bell JM, Tumidge JD, et al. Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program [J]. J Antimicrob Chemother, 2009, 63(1):55-59.
5. Mak JK, Kim MJ, Pham J, et al. Antibiotic resistance determinants in nosocomial strains of multidrug-resistant Acinetobacter baumannii [J]. J Antimicmb Chemother, 2009, 63(1):47-54.
6. Bassetti M, Righi E, Esposito S, et al. Drug treatment for multidrug-resistant Acinetobacter baumannii infections [J]. Future Microbiol, 2008, 3(6):649-660.
7. Vila J, Pachon J. Therapeutic options for Acinetobacter baumannii infections [J]. Expert Opin Pharmaco, 2008, 9(4): 587-599. (Pubitemid 351425386)
8. Pachon J, Vila J. Treatment of multiresistant Acinetobacter baumannii infections [J]. Curr Opin Investig Drugs, 2009, 10(2):150-156.
9. Corbella X, Ariza J, Ardanuy C, et al. Efficacy of sulbactam alone and in combination with ampieillin in nosocomial infections caused by muhiresistant Acinetobacter baumannii [J]. J Antimierob Chemother, 1998, 42(6):793-802.
10. Karageorgopoulos DE, Falagas ME. Current control and treatment of multidrug-resistant Acinetobacter baumannii infections [J]. Lancet Infect Dis, 2008, 8(12):751-762.
11. Dalla-Costa LM, Coelho JM, Souza HA, et al. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil [J]. J Clin Microbiol, 2003, 41(7):3403-3406. (Pubitemid 36842361)
12. Del Mar Tomas M, Caretelle M, Pertega S, et al. Hospital out-break caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factor for colonisation and infection [J]. Clin Microbiol Infect, 2005, 11(7):540-546. (Pubitemid 40895153)